Clinical Characteristics and Outcomes in Patients Diagnosed With Novel Influenza A (H1N1)
| Status: | Recruiting |
|---|---|
| Conditions: | Influenza |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 6/15/2018 |
| Start Date: | October 2009 |
| End Date: | December 2025 |
| Contact: | Fernanda Silveira, MD |
| Email: | silveirafd@upmc.edu |
| Phone: | 412-648-6401 |
This is study where medical record information will be collected as well as collection of
excess biological samples.
excess biological samples.
Patients diagnosed with H1N1 will be asked to consent and allow us to collect the following:
From the medical record the research staff will review and record the results of the
test/procedures (x-rays, CT-scans, EKG (electrocardiogram), etc.) that are part of the
subjects clinical care and the results will become part of the research record. We will also
collect and record vitals signs, including temperature, blood pressure, heart rate,
respiratory rate and record the list of medications the subject is taking. We will also
collect information on demographics (address, phone number, etc.) including gender, race and
ethnicity, review and record past medical history and any non medical procedures that the
subject may have had within the past two months. This information will be collected by the
research coordinator from the medical record.
The clinical physician ordered a nasopharyngeal swab or obtained bronchoalveolar lavage fluid
to diagnose novel Influenza A (H1N1). We will collect this swab or fluid after the diagnosis
has been made, to evaluate the genetic material of the virus. This swab or fluid is normally
discarded once the diagnosis is made.
collection of data will be done by the research staff and should not take any longer than
15-20 minutes. The clinical samples that would have been discarded will be collected by the
research staff from microbiology and pathology and delivered to the research lab in Scaife.
The investigators will do a 6 month follow up phone call to check the health status of the
participant. This will be done by the research coordinator and take no more than 5-10 minutes
of the subject's time.
From the medical record the research staff will review and record the results of the
test/procedures (x-rays, CT-scans, EKG (electrocardiogram), etc.) that are part of the
subjects clinical care and the results will become part of the research record. We will also
collect and record vitals signs, including temperature, blood pressure, heart rate,
respiratory rate and record the list of medications the subject is taking. We will also
collect information on demographics (address, phone number, etc.) including gender, race and
ethnicity, review and record past medical history and any non medical procedures that the
subject may have had within the past two months. This information will be collected by the
research coordinator from the medical record.
The clinical physician ordered a nasopharyngeal swab or obtained bronchoalveolar lavage fluid
to diagnose novel Influenza A (H1N1). We will collect this swab or fluid after the diagnosis
has been made, to evaluate the genetic material of the virus. This swab or fluid is normally
discarded once the diagnosis is made.
collection of data will be done by the research staff and should not take any longer than
15-20 minutes. The clinical samples that would have been discarded will be collected by the
research staff from microbiology and pathology and delivered to the research lab in Scaife.
The investigators will do a 6 month follow up phone call to check the health status of the
participant. This will be done by the research coordinator and take no more than 5-10 minutes
of the subject's time.
Inclusion Criteria:
- Patients diagnosed with H1N1
Exclusion Criteria:
- does not meet entry criteria
We found this trial at
1
site
Pittsburgh, Pennsylvania 15213
Principal Investigator: Fernanda Silveira, MD
Phone: 412-648-6401
Click here to add this to my saved trials
